Mineralys Therapeutics, Inc. (MLYS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.

Greetings. Welcome to Mineralys third-quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce Dan ...

Florida’s Retirees Are Fleeing: Experts Predict These 5 States Will Be Top Retirement Spots in 10 Years ...

We recently completed enrollment in our pivotal Advance-HTN trial which is evaluating the efficacy and safety of lorundrostat ...

Mineralys Therapeutics, Inc. ( (MLYS) ) has released its Q3 earnings. Here is a breakdown of the information Mineralys ...

Rami Katkhuda, an analyst from LifeSci Capital, maintained the Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report). The ...

Hypertension (HTN) increases the risk of development of HF and it precedes it in 75% of cases. HF patients are nearly evenly divided between those with reduced left ventricular (LV) function or ...

While 16/8 fasting may offer health benefits, it’s not suitable for everyone. "Individuals with diabetes, hypoglycaemia, or ...

A 58-year-old male patient from Tripura was successfully treated for critical illnesses including septic shock and multi-organ dysfunction syndrome after 32 days at Father Muller Medical College ...

The 10-Q report also outlined the clinical highlights, including the ongoing clinical trials for lorundrostat, such as the ...

While medical headlines often focus on the biochemical underpinnings of disease, our body's biomechanics are equally crucial.

Men were more likely than women to have high blood pressure, federal officials found, but men were also less likely than women to know they had hypertension.